D.SH. Zhakenov
D.SH. Zhakenov has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Zinigul Sarmurzina
«Республикалық микроорганизмдер коллекциясы» ЖШС, Астана, Қазақстан
3 shared publications - Г.н. Бисенова
«Республикалық микроорганизмдер коллекциясы» ЖШС, Астана, Қазақстан
3 shared publications - B.K. Mussabayeva
«Республикалық микроорганизмдер коллекциясы» ЖШС, Астана, Қазақстан
2 shared publications - Zh. Bekshin
Republican Collection of Microorganisms, Astana 010000, Kazakhstan
2 shared publications Н.т. Амирханова
«Республикалық микроорганизмдер коллекциясы» ЖШС, Астана, Қазақстан
2 shared publications- A. Ergalieva1 shared publication
Latest Publications
- Open Access
- 20 September 2026
- Published by al-Farabi Kazakh National University in Experimental Biology
- Vol. 108 (3) , 168-185
АҒЫНДЫ СУЛАРДАҒЫ ПОЛИФОСФАТ ЖИНАҚТАУШЫ ОРГАНИЗМДЕРДІҢ АЛУАНТҮРЛІЛІГІ МЕН МЕТАБОЛИКАЛЫҚ ЕРЕКШЕЛІКТЕРІ
Efficient phosphorus removal from wastewater has become a critical focus in contemporary environmental safety and sustainable water resource management. Although phosphorus (P) is an essential biological element for living organisms, its excessive discharge into natural water bodies triggers eutrophication, leading to the degradation of aquatic ecosystems. Furthermore, high P concentrations induce oxygen depletion, which ultimately drives a decline in biodiversity. Consequently, mitigating P pollution in wastewater is widely recognized as a pressing challenge for environmental protection and sustainable development. While traditional physical and chemical methods offer certain removal efficiencies, they inherently require substantial chemical reagents, generate secondary sludge, and increase operational costs. To overcome these limitations, enhanced biological phosphorus removal (EBPR) technologies have received significant attention in recent years. The EBPR process has been shown to reduce wastewater P to very low levels without the need for chemical precipitants. This mechanism relies on the capability of polyphosphate-accumulating organisms (PAOs) to take up large amounts of P and store it intracellularly as polyphosphate (РolyP). Under alternating anaerobic and aerobic conditions, PAOs achieve highly efficient P removal. As a result, EBPR technology represents an environmentally friendly, cost-effective, and long-term sustainable system. Thus, leveraging microorganisms to eliminate phosphorus-containing compounds from wastewater stands out as a promising frontier in modern water treatment biotechnology. This approach is expected to protect aquatic ecosystems, enhance wastewater treatment efficiency, and reduce anthropogenic pressure. In this review, we address current knowledge gaps in research regarding the microorganisms employed for P removal, focusing specifically on their phylogenetic diversity and metabolic characteristics.
- 20 September 2026
- Published by al-Farabi Kazakh National University in Experimental Biology
- Vol. 108 (3) , 168-185
Open AccessАҒЫНДЫ СУЛАРДАҒЫ ПОЛИФОСФАТ ЖИНАҚТАУШЫ ОРГАНИЗМДЕРДІҢ АЛУАНТҮРЛІЛІГІ МЕН МЕТАБОЛИКАЛЫҚ ЕРЕКШЕЛІКТЕРІ
Efficient phosphorus removal from wastewater has become a critical focus in contemporary environmental safety and sustainable water resource management. Although phosphorus (P) is an essential biological element for living organisms, its excessive discharge into natural water bodies triggers eutrophication, leading to the degradation of aquatic ecosystems. Furthermore, high P concentrations induce oxygen depletion, which ultimately drives a decline in biodiversity. Consequently, mitigating P pollution in wastewater is widely recognized as a pressing challenge for environmental protection and sustainable development. While traditional physical and chemical methods offer certain removal efficiencies, they inherently require substantial chemical reagents, generate secondary sludge, and increase operational costs. To overcome these limitations, enhanced biological phosphorus removal (EBPR) technologies have received significant attention in recent years. The EBPR process has been shown to reduce wastewater P to very low levels without the need for chemical precipitants. This mechanism relies on the capability of polyphosphate-accumulating organisms (PAOs) to take up large amounts of P and store it intracellularly as polyphosphate (РolyP). Under alternating anaerobic and aerobic conditions, PAOs achieve highly efficient P removal. As a result, EBPR technology represents an environmentally friendly, cost-effective, and long-term sustainable system. Thus, leveraging microorganisms to eliminate phosphorus-containing compounds from wastewater stands out as a promising frontier in modern water treatment biotechnology. This approach is expected to protect aquatic ecosystems, enhance wastewater treatment efficiency, and reduce anthropogenic pressure. In this review, we address current knowledge gaps in research regarding the microorganisms employed for P removal, focusing specifically on their phylogenetic diversity and metabolic characteristics.
- Open Access
- 30 March 2026
- Published by S.Seifullin Kazakh Agro Technical University in Central Asian Journal of Veterinary Science
- No. 1(013),p. 5-18
Antibiotic resistance and the safety of probiotic microorganisms
Background and Aim. Antibiotic resistance is a global threat to health. One of the current safety concerns regarding probiotic microorganisms is their antibiotic resistance, which is often associated with mobile genetic elements. There are risks of horizontal gene transfer of antibiotic resistance genes from commercial probiotic microorganisms - used in biologics, food, and feed additives - to pathogens affecting humans and domestic animals.Materials and Methods. In this work, the criteria for assessing the safety of probiotic microorganisms, as set by researchers and national regulatory bodies, are summarised. The safety criteria set out in the most well known QPS and GRAS systems are analysed in detail. The literature on the antibiotic resistance of probiotic microorganisms was analysed from the followingaspects: intrinsic and acquired resistance; phenotypic and genotypic profiles; species- and strain-level differences, and the role of the ecological niche.Results. This study presents the results of an analysis of the safety and antibiotic resistance of probiotic microorganisms employed as biopreparations in public health measures, veterinary medicine, and the food industry. Safety assessment relies on a comprehensive approach, including the genetic characteristics of probiotic strains. The priority of full-genome sequencing and bioinformatic analysis is emphasised, as these enable a detailed review of the probiotic microorganism genome for the presence of genes determining the synthesis of virulence factors, antibiotic resistance, bioamines, and others.Conclusion. The review emphasizes the importance of assessing the safety and antibiotic resistance of strains of lactic acid bacteria. Whole-genome sequencing of the strain is considered a priority.
- 30 March 2026
- Published by S.Seifullin Kazakh Agro Technical University in Central Asian Journal of Veterinary Science
- No. 1(013),p. 5-18
Open AccessAntibiotic resistance and the safety of probiotic microorganisms
Background and Aim. Antibiotic resistance is a global threat to health. One of the current safety concerns regarding probiotic microorganisms is their antibiotic resistance, which is often associated with mobile genetic elements. There are risks of horizontal gene transfer of antibiotic resistance genes from commercial probiotic microorganisms - used in biologics, food, and feed additives - to pathogens affecting humans and domestic animals.Materials and Methods. In this work, the criteria for assessing the safety of probiotic microorganisms, as set by researchers and national regulatory bodies, are summarised. The safety criteria set out in the most well known QPS and GRAS systems are analysed in detail. The literature on the antibiotic resistance of probiotic microorganisms was analysed from the followingaspects: intrinsic and acquired resistance; phenotypic and genotypic profiles; species- and strain-level differences, and the role of the ecological niche.Results. This study presents the results of an analysis of the safety and antibiotic resistance of probiotic microorganisms employed as biopreparations in public health measures, veterinary medicine, and the food industry. Safety assessment relies on a comprehensive approach, including the genetic characteristics of probiotic strains. The priority of full-genome sequencing and bioinformatic analysis is emphasised, as these enable a detailed review of the probiotic microorganism genome for the presence of genes determining the synthesis of virulence factors, antibiotic resistance, bioamines, and others.Conclusion. The review emphasizes the importance of assessing the safety and antibiotic resistance of strains of lactic acid bacteria. Whole-genome sequencing of the strain is considered a priority.
- Open Access
- 31 August 2025
- Published by Salidat Kairbekova National Research Center for Health Development in Journal of Health Development
- Vol. 60 (4)
Қазақстан Республикасындағы және көршілес елдердегі туберкулездің эпидемиологиялық жағдайы
This article discusses the epidemiological situation of the global problem associated with the spread of tuberculosis in neighboring countries and in the Republic of Kazakhstan. The World Health Organization (WHO) is actively working on its elimination, aiming to reduce morbidity, mortality and financial costs associated with tuberculosis. According to the forecasts of the United Nations within the framework of the Tuberculosis Elimination Strategy and Sustainable Development Goals, the tuberculosis epidemic is expected to be eliminated by 2030. To achieve these goals, it is essential to monitor progress in the implementation of the plans, identify problem areas, and evaluate the effectiveness of the measures taken to eliminate tuberculosis. To date, tuberculosis remains one of the main infectious diseases in the countries of Eurasia, where historically complex epidemiological prerequisites have been formed. This study analyzes the dynamics of the spread of the disease in the period from 2019 to 2023, identifies key risk factors and substantiates the importance of creating comprehensive measures aimed at reducing the incidence of the disease. Kazakhstan and its neighboring countries (Russia, China, Uzbekistan, Kyrgyzstan and Turkmenistan), constitute a region with heterogeneous tuberculosis incidence rates, which is explained by a combination of socio-economic, geographical and medical factors. One of the factors influencing the spread of tuberculosis is the growing number of migrants in transit countries with border areas of Kazakhstan. According to the WHO, countries near Kazakhstan with economically high-income economies and steadily developing medical infrastructure such as Russia and China, have demonstrated improvement in the epidemiological situation of tuberculosis morbidity. However, despite declining incidence and availability of effective treatment, the incidence of tuberculosis in Kazakhstan and neighboring countries remains high and requires the introduction of a comprehensive approach of preventive measures, early diagnosis, application of advanced treatment methods, and raising public awareness. The main objective of this study is to assess the epidemiological situation in Kazakhstan and in geographically close countries.
- 31 August 2025
- Published by Salidat Kairbekova National Research Center for Health Development in Journal of Health Development
- Vol. 60 (4)
Open AccessҚазақстан Республикасындағы және көршілес елдердегі туберкулездің эпидемиологиялық жағдайы
This article discusses the epidemiological situation of the global problem associated with the spread of tuberculosis in neighboring countries and in the Republic of Kazakhstan. The World Health Organization (WHO) is actively working on its elimination, aiming to reduce morbidity, mortality and financial costs associated with tuberculosis. According to the forecasts of the United Nations within the framework of the Tuberculosis Elimination Strategy and Sustainable Development Goals, the tuberculosis epidemic is expected to be eliminated by 2030. To achieve these goals, it is essential to monitor progress in the implementation of the plans, identify problem areas, and evaluate the effectiveness of the measures taken to eliminate tuberculosis. To date, tuberculosis remains one of the main infectious diseases in the countries of Eurasia, where historically complex epidemiological prerequisites have been formed. This study analyzes the dynamics of the spread of the disease in the period from 2019 to 2023, identifies key risk factors and substantiates the importance of creating comprehensive measures aimed at reducing the incidence of the disease. Kazakhstan and its neighboring countries (Russia, China, Uzbekistan, Kyrgyzstan and Turkmenistan), constitute a region with heterogeneous tuberculosis incidence rates, which is explained by a combination of socio-economic, geographical and medical factors. One of the factors influencing the spread of tuberculosis is the growing number of migrants in transit countries with border areas of Kazakhstan. According to the WHO, countries near Kazakhstan with economically high-income economies and steadily developing medical infrastructure such as Russia and China, have demonstrated improvement in the epidemiological situation of tuberculosis morbidity. However, despite declining incidence and availability of effective treatment, the incidence of tuberculosis in Kazakhstan and neighboring countries remains high and requires the introduction of a comprehensive approach of preventive measures, early diagnosis, application of advanced treatment methods, and raising public awareness. The main objective of this study is to assess the epidemiological situation in Kazakhstan and in geographically close countries.
- 30 June 2025
- Published by Karagandy University of the name of academician E.A. Buketov in Fundamental and Experimental Biology
- Vol. 11830 (2) , 55-61
Study of the prevalence of ESKAPE pathogens and their resistance to antimicrobial drugs
A prospective microbiological study of the prevalence of ESKAPE microorganisms and antibiotic resistance rates of strains was conducted in patients of the pediatric cardiac surgery department of a highly specialized clinic in the period from 2019 to 2023. During the study, classical routine bacterial methods for identifying isolates were used, as well as the automated system for final identification and susceptibility testing Vitek 2 - Compact. The study included 3725 clinical samples, the frequency of pathogen detection was: S.aureus 35.2%, K.pneumoniae 27.3%, A.baumannii 14.5%, Ps.aeruginosa 12.4%, Enterobacter sp. 8.7% and Enterococcus faecium 1.2%. A significant increase in resistance was detected in MRSA from 13.7% to 41.9% (p = 0.041), in K.pneumoniae, resistance to carbapenems increased from 0% to 8.3% (p = 0.057), while we note a decrease in the prevalence of ESBL-producing strains of K.pneumoniae from 63.3%. to 45.2% (p=0.058), resistance to carbapenems in P.aeruginosa strains decreased from 64.3% to 37.7% (p=0.037), and in A.baumannii from 48.5% to 19.1% (p=0.039). According to the obtained results, in our pediatric cardiac surgery department, ESKAPE pathogens accounted for 64.2%. The most common isolates were S.aureus, K.pneumoniae and A.baumannii, while there was a sharply increasing trend towards resistance of K.pneumoniae to carbapenems and MRSA. Our results showed that well-designed infection control in each hospital is necessary, including a good hygiene strategy, microbiological monitoring and in-hospital control. Keywords: microbiological monitoring, ESKAPE microorganisms, prevalence, antibiotic resistance, pediatric cardiac surgery.
- 30 June 2025
- Published by Karagandy University of the name of academician E.A. Buketov in Fundamental and Experimental Biology
- Vol. 11830 (2) , 55-61
Study of the prevalence of ESKAPE pathogens and their resistance to antimicrobial drugs
A prospective microbiological study of the prevalence of ESKAPE microorganisms and antibiotic resistance rates of strains was conducted in patients of the pediatric cardiac surgery department of a highly specialized clinic in the period from 2019 to 2023. During the study, classical routine bacterial methods for identifying isolates were used, as well as the automated system for final identification and susceptibility testing Vitek 2 - Compact. The study included 3725 clinical samples, the frequency of pathogen detection was: S.aureus 35.2%, K.pneumoniae 27.3%, A.baumannii 14.5%, Ps.aeruginosa 12.4%, Enterobacter sp. 8.7% and Enterococcus faecium 1.2%. A significant increase in resistance was detected in MRSA from 13.7% to 41.9% (p = 0.041), in K.pneumoniae, resistance to carbapenems increased from 0% to 8.3% (p = 0.057), while we note a decrease in the prevalence of ESBL-producing strains of K.pneumoniae from 63.3%. to 45.2% (p=0.058), resistance to carbapenems in P.aeruginosa strains decreased from 64.3% to 37.7% (p=0.037), and in A.baumannii from 48.5% to 19.1% (p=0.039). According to the obtained results, in our pediatric cardiac surgery department, ESKAPE pathogens accounted for 64.2%. The most common isolates were S.aureus, K.pneumoniae and A.baumannii, while there was a sharply increasing trend towards resistance of K.pneumoniae to carbapenems and MRSA. Our results showed that well-designed infection control in each hospital is necessary, including a good hygiene strategy, microbiological monitoring and in-hospital control. Keywords: microbiological monitoring, ESKAPE microorganisms, prevalence, antibiotic resistance, pediatric cardiac surgery.
- Open Access
- 28 September 2023
- Published by S.Seifullin Kazakh Agro Technical University in HERALD OF SCIENCE OF S SEIFULLIN KAZAKH AGRO TECHNICAL RESEARCH UNIVERSITY: Veterinary sciences
- No. 3(003),p. 42-49
VIABILITY AND ANTAGONISM OF CRYOPRESERVED LACTIC ACID BACTERIA
Preserving and advancing bioresources involving industrial microorganisms is of paramount importance for every nation. However, long-term storage of these strains often leads to diminished viability and biological activity. Thus, it is crucial to investigate the properties of cryopreserved strains stored at -80°C in a 10% glycerol solution within low-temperature refrigerators. This study aimed to comparatively analyze the viability of 129 lactic acid bacteria strains, including Lactobacillus sp., Lactococcus sp., and Pediococcus sp., cryopreserved from 2006 to 2020. Among them, 93 Lactobacillus sp. strains were categorized into three groups based on storage dates (2006-2007, 2013-2014, and 2017-2020). Viability titers were determined using the standard serial dilution method, counting microorganisms in CFU/ml. Regardless of the storage duration or species affiliation, the study identified lactic acid bacteria strains exhibiting both high (107 - 109 CFU/ml) and low (104-106 CFU/ml) viability titers. Additionally, the antagonistic activity of 33 Lactobacillus sp. strains was investigated using the delayed antagonism method, subdividing them into 17 strains with sufficiently high viability titers and 16 strains with low viability titers. The results revealed that 20% of strains with high viability titers and 27% with low viability titers exhibited relatively high antagonistic activity (with a zone of inhibition ranging from 10 to 18 mm). In both groups, strains with low antagonistic activity (with a zone of inhibition measuring 5-9 mm), particularly against Gram-positive and Gram-negative bacterial test-cultures, predominated. Significantly, 51% of lactobacilli strains demonstrated pronounced antagonism against Candida albicans ATCC- 885-653 test-culture. These findings underscore the practical importance of the study, emphasizing the necessity to analyze and select optimal concentrations of intracellular or extracellular cryopreservatives and to determine the initial viability titer when storing strains for cryopreservation. Tailoring cryopreservation solutions to each strain can enhance the preservation of their original properties, ultimately improving overall preservation quality.
- 28 September 2023
- Published by S.Seifullin Kazakh Agro Technical University in HERALD OF SCIENCE OF S SEIFULLIN KAZAKH AGRO TECHNICAL RESEARCH UNIVERSITY: Veterinary sciences
- No. 3(003),p. 42-49
Open AccessVIABILITY AND ANTAGONISM OF CRYOPRESERVED LACTIC ACID BACTERIA
Preserving and advancing bioresources involving industrial microorganisms is of paramount importance for every nation. However, long-term storage of these strains often leads to diminished viability and biological activity. Thus, it is crucial to investigate the properties of cryopreserved strains stored at -80°C in a 10% glycerol solution within low-temperature refrigerators. This study aimed to comparatively analyze the viability of 129 lactic acid bacteria strains, including Lactobacillus sp., Lactococcus sp., and Pediococcus sp., cryopreserved from 2006 to 2020. Among them, 93 Lactobacillus sp. strains were categorized into three groups based on storage dates (2006-2007, 2013-2014, and 2017-2020). Viability titers were determined using the standard serial dilution method, counting microorganisms in CFU/ml. Regardless of the storage duration or species affiliation, the study identified lactic acid bacteria strains exhibiting both high (107 - 109 CFU/ml) and low (104-106 CFU/ml) viability titers. Additionally, the antagonistic activity of 33 Lactobacillus sp. strains was investigated using the delayed antagonism method, subdividing them into 17 strains with sufficiently high viability titers and 16 strains with low viability titers. The results revealed that 20% of strains with high viability titers and 27% with low viability titers exhibited relatively high antagonistic activity (with a zone of inhibition ranging from 10 to 18 mm). In both groups, strains with low antagonistic activity (with a zone of inhibition measuring 5-9 mm), particularly against Gram-positive and Gram-negative bacterial test-cultures, predominated. Significantly, 51% of lactobacilli strains demonstrated pronounced antagonism against Candida albicans ATCC- 885-653 test-culture. These findings underscore the practical importance of the study, emphasizing the necessity to analyze and select optimal concentrations of intracellular or extracellular cryopreservatives and to determine the initial viability titer when storing strains for cryopreservation. Tailoring cryopreservation solutions to each strain can enhance the preservation of their original properties, ultimately improving overall preservation quality.